Cortes J, Hurvitz SA, O'Shaughnessy J, Delaloge S, et al. Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. J Clin Oncol 2024 Jun 18:JCO2302036. doi: 10.1200/JCO.23.02036.
PMID: 38889373